You have   6 free profiles   left this month    Start Your Free Trial ➤
Hey, we noticed you're a RelSci Pro subscriber! Would you like to view the page there? View on RelSci Pro ➤

Daniel N. Swisher, Jr.

President & Chief Operating Officer at Jazz Pharmaceuticals Plc
Overview
Relationships
In The News
Paths
Education
Career History
Boards & Committees
Non-Profit Donations & Grants
Political Donations
Public Holdings
Transactions
Events

Daniel N. Swisher, Jr.

President & Chief Operating Officer at Jazz Pharmaceuticals Plc

Overview

Age
55 (Born 1963)
Notable Companies
Jazz Pharmaceuticals Plc

Jazz Pharmaceuticals (EUSA Pharma USA), Inc.

Sunesis Pharmaceuticals, Inc.
Board Seats
5
Number of Relationships
This person is connected to 805 people.

Relationships See Details


Co-Founder at Jazz Pharmaceuticals, Inc.

President & Chief Executive Officer at Cerus Corp.

President, Research & Development, Senior Vice President & Chief Scientific Officer at Amarin Corporation Plc

Venture Partner at 5AM Venture Management LLC

Former Executive Vice President & Chief Financial Officer, Onyx Pharmaceuticals at Dermira, Inc.

Chief Scientific Officer at Cerus Corp.

Co-Founder at Corcept Therapeutics, Inc.

Consultant at Sunesis Pharmaceuticals, Inc.

Partner at Venrock Associates

Partner at Sutter Hill Ventures LLC
See 795 more listings with RelSci Professional.

In The News See More

RelSci
January 12, 2018
RelSci
January 10, 2018
RelSci
January 6, 2018
RelSci
December 11, 2017
FierceBiotech
December 8, 2017
See full news coverage and complete stories with RelSci Professional.

Paths to Daniel N. Swisher, Jr.

Daniel N. Swisher, Jr.
You
Connections via Relationship Science
Daniel N. Swisher, Jr.
Sync your contacts to see how you can connect with Daniel N. Swisher, Jr..

Educational Background

B.A. 
Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.
M.B.A. 
The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Career History

President & Chief Operating Officer
2018 - Current
• About Us • Mission & Values • Management Team • Board of Directors • Board Committees • Commercial Capabilities • Corporate Responsibility • Ethical Sales & Marketing • Drug Safety & Medical Info • Physician Data Restriction Program • California Compliance Declaration • Stories • What’s in a Name? • Business Development • Locations ABOUT US Jazz Pharmaceuticals plc is an international specialty biopharmaceutical company dedicated to helping patients with unmet medical needs. We identify, develop and commercialize innovative products in focused therapeutic areas, with a strong commercial focus and expertise in narcolepsy, oncology, pain and psychiatry. Our marketed product portfolio includes: XYREM® (sodium oxybate), ERWINAZETM (asparaginase Erwinia chrysanthemi), PRIALT® (ziconotide) solution, intrathecal infusion, FAZACLO® (clozapine, USP) LD and HD , and LUVOX CR® (fluvoxamine maleate). The product information on XYREM, ERWINAZE, PRIALT, FAZACLO LD, FAZACLO HD and LUVOX CR is intended only for residents of the United States. For more information, including complete prescribing information and boxed warnings, click on the product names above. Please visit www.EUSAPharma.com for more information about our international division, EUSA Pharma, and our products marketed outside the U.S. We plan to build upon our portfolio of products through acquisition and/or in-licensing activities, and leveraging our unique commercial expertise. As we evaluate additional acquisition and in-licensing opportunities, we work closely with healthcare professionals and patient advocates to identify significant treatment gaps where Jazz Pharmaceuticals’ unique approach to patient care and patient-focused products may be able to bring a new therapeutic option to the market where none existed previously.
President & Chief Operating Officer
2017 - Current
Jazz Pharmaceuticals (EUSA Pharma USA), Inc. develops and markets biopharmaceutical products. The company was founded on November 7, 1980 and is headquartered in Princeton, NJ.
President, Chief Executive Officer, Secretary & Director
2001 - 2017
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The firms activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.
Senior Vice President-Sales & Marketing
1992 - 2001
ALZA Corp. provides drug delivery solutions and develops pharmaceutical products. The company applies its delivery technologies to develop pharmaceutical products with enhanced therapeutic value for its own portfolio and for many of the world's leading pharmaceutical companies. The company was founded by Martin Gerstel and Alejandro Zaffaroni in 1968 and is headquartered in Vacaville, CA.

Boards & Committees

Corporate Boards ▾
Independent Director
2015 - Current
Corcept Therapeutics, Inc. engages in the development of drugs for the treatment of severe psychiatric, neurological, and metabolic disorders. It focuses on the development of drugs for disorders that are associated with a steroid hormone called cortisol. Its products include korlym and korlym support. The company was founded by David B. Singer and Joseph K. Belanoff on May 13, 1998 and is headquartered in Menlo Park, CA.
Chairman, Board of Directors
2011 - Current
Cerus Corp. engages in the research, development, and manufacture of biomedical and surgical products. It produces blood system for platelets and plasma. It markets its products under the INTERCEPT brand. The company was founded by Laurence M. Corash and John E. Hearst on September 19, 1991 and is headquartered in Concord, CA.
Strategic Advisor, Board of Directors
2003 - 2018
Sunesis Pharmaceuticals, Inc. engages in the development and commercialization of new oncology therapeutics for the treatment of solid and hematologic cancers. Its efforts are currently focused primarily on the development of vosaroxin for the treatment of acute myeloid leukemia. The firms activities include conducting research and development internally and through corporate collaborators, in-licensing and out-licensing pharmaceutical compounds and technology, conducting clinical trials and raising capital. The company was founded on February 10, 1998 and is headquartered in South San Francisco, CA.
Non-Profit Boards ▾
Director
2007 - Current
TO PROVIDE MENTORING, PEER SUPPORT, RESPITE AND RECREATIONAL PROGRAMS FOR ALL MEMBERS OF FAMILIES AFFECTED BY CHILDHOOD CANCER.
Council Member-1954
Tenure Unconfirmed

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
N/A
2005
The Stanford Graduate School of Business has built an international reputation based on its innovative programs, which include: Two-year MBA Program, designed to educate business leaders One-year Stanford Sloan Master’s Program for mid-career executives PhD Program for future academics Executive Education programs for experienced managers Faculty research program Academic programs, including the two-year MBA, the 12-month Sloan Master's Program, and the PhD program, create a transformational student experience that reflects the tagline: Change lives. Change organizations. Change the world. Today the state-of-the-art Knight Management Center complex enables Stanford's innovative, globalized MBA curriculum, offering flexible classroom spaces for hands-on experiential learning small-group leadership labs, and team-based learning. It engages faculty and students across Stanford University, as well as alumni, global executives, and the broader world community.

Political Donations

$250
2014
Representative at Office of the Representative from California's 18th District, Anna Eshoo
$250
2009
Representative at Office of the Representative from California's 18th District, Anna Eshoo
$250
2006
Representative at Office of the Representative from California's 18th District, Anna Eshoo
$250
2001
Representative at Office of the Representative from California's 18th District, Anna Eshoo
$200
2000
Representative at Office of the Representative from California's 19th District, Zoe Lofgren
See 1 more listing with RelSci Professional.

Public Holdings

Restricted data only for RelSci Professional users.

Transactions

Details Hidden
Sunesis Pharmaceuticals, Inc. raised money in a private placement transaction
Details Hidden
Sunesis Pharmaceuticals, Inc. raised money in a private placement transaction

Events

Speaker
New York City, NY
2013 UBS Global Healthcare Conference

Other Affiliations

You've reached your 7 free profiles limit this month.

Upgrade to RelSci Pro today to enjoy unlimited profile views and much more!

Start My Free Trial
Still not convinced? Check out our full listing of features here.